OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Metabolic dysfunction-associated fatty liver disease increases risk of chronic kidney disease: a systematic review and meta-analysis
Jianghua Zhou, Dan‐Qin Sun, Giovanni Targher, et al.
eGastroenterology (2023) Vol. 1, Iss. 1, pp. e100005-e100005
Open Access | Times Cited: 11
Jianghua Zhou, Dan‐Qin Sun, Giovanni Targher, et al.
eGastroenterology (2023) Vol. 1, Iss. 1, pp. e100005-e100005
Open Access | Times Cited: 11
Showing 11 citing articles:
Current status and future trends of the global burden of MASLD
Lei Miao, Giovanni Targher, Christopher D. Byrne, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 8, pp. 697-707
Closed Access | Times Cited: 169
Lei Miao, Giovanni Targher, Christopher D. Byrne, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 8, pp. 697-707
Closed Access | Times Cited: 169
NUP85 alleviates lipid metabolism and inflammation by regulating PI3K/AKT signaling pathway in nonalcoholic fatty liver disease
Yincui Wu, Qi Yan, Si-qing Yue, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 6, pp. 2219-2235
Open Access | Times Cited: 7
Yincui Wu, Qi Yan, Si-qing Yue, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 6, pp. 2219-2235
Open Access | Times Cited: 7
Deciphering metabolic dysfunction‐associated steatotic liver disease: insights from predictive modeling and clustering analysis
Kazuma Mori, Yukinori Akiyama, Marenao Tanaka, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 7, pp. 1382-1393
Open Access | Times Cited: 6
Kazuma Mori, Yukinori Akiyama, Marenao Tanaka, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 7, pp. 1382-1393
Open Access | Times Cited: 6
Serum PRO‐C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort
Liang‐Jie Tang, Dan‐Qin Sun, Sherlot Juan Song, et al.
Liver International (2024) Vol. 44, Iss. 5, pp. 1129-1141
Closed Access | Times Cited: 5
Liang‐Jie Tang, Dan‐Qin Sun, Sherlot Juan Song, et al.
Liver International (2024) Vol. 44, Iss. 5, pp. 1129-1141
Closed Access | Times Cited: 5
Metabolic dysfunction-associated fatty liver disease and heavy alcohol consumption increase mortality:A nationwide study
So Hyun Cho, Seohyun Kim, Rosa Oh, et al.
Hepatology International (2024) Vol. 18, Iss. 4, pp. 1168-1177
Closed Access | Times Cited: 4
So Hyun Cho, Seohyun Kim, Rosa Oh, et al.
Hepatology International (2024) Vol. 18, Iss. 4, pp. 1168-1177
Closed Access | Times Cited: 4
Metabolic dysfunction-associated steatotic liver disease: Navigating terminological evolution, diagnostic frontiers and therapeutic horizon-an editorial exploration
Aleksandra Bołdys, Łukasz Bułdak
World Journal of Gastroenterology (2024) Vol. 30, Iss. 18, pp. 2387-2390
Open Access | Times Cited: 2
Aleksandra Bołdys, Łukasz Bułdak
World Journal of Gastroenterology (2024) Vol. 30, Iss. 18, pp. 2387-2390
Open Access | Times Cited: 2
Unlocking the Therapeutic Potential of Ellagic Acid for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
Tharani Senavirathna, Armaghan Shafaei, Ricky R. Lareu, et al.
Antioxidants (2024) Vol. 13, Iss. 4, pp. 485-485
Open Access | Times Cited: 1
Tharani Senavirathna, Armaghan Shafaei, Ricky R. Lareu, et al.
Antioxidants (2024) Vol. 13, Iss. 4, pp. 485-485
Open Access | Times Cited: 1
Non-obese non-alcoholic fatty liver disease and the risk of chronic kidney disease: a systematic review and meta-analysis
Yixian You, Pei Xiong, Jiang Wei, et al.
PeerJ (2024) Vol. 12, pp. e18459-e18459
Open Access | Times Cited: 1
Yixian You, Pei Xiong, Jiang Wei, et al.
PeerJ (2024) Vol. 12, pp. e18459-e18459
Open Access | Times Cited: 1
MAFLD as a predictor of adverse cardiovascular events among CHD patients with LDL-C<1.8 mmol/L
Jingjing Song, Yu‐Peng Liu, Ye Liu, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024), pp. 103798-103798
Closed Access
Jingjing Song, Yu‐Peng Liu, Ye Liu, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024), pp. 103798-103798
Closed Access
Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease
Liang‐Jie Tang, Dan‐Qin Sun, Sherlot Juan Song, et al.
Research Square (Research Square) (2023)
Open Access
Liang‐Jie Tang, Dan‐Qin Sun, Sherlot Juan Song, et al.
Research Square (Research Square) (2023)
Open Access
